A detailed history of Israel Englander (Millennium Management LLC) transactions in Repligen Corp stock. As of the latest transaction made, Millennium Management LLC holds 53,600 shares of RGEN stock, worth $7.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,600
Previous 50,500 6.14%
Holding current value
$7.6 Million
Previous $6.37 Million 25.29%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $76.3 Million - $107 Million
-636,708 Reduced 84.21%
119,410 $17.8 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $90.7 Million - $138 Million
756,118 New
756,118 $95.3 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $13.3 Million - $21.5 Million
116,110 Added 1110.36%
126,567 $22.8 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $2.38 Million - $3.11 Million
-17,226 Reduced 62.23%
10,457 $1.48 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $4.27 Million - $5.48 Million
27,683 New
27,683 $4.66 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $4.6 Million - $7.35 Million
-28,680 Reduced 20.43%
111,687 $20.9 Million
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $19.1 Million - $25.5 Million
135,725 Added 2923.85%
140,367 $22.8 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $49.1 Million - $78.6 Million
-304,840 Reduced 98.5%
4,642 $873,000
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $46.1 Million - $56.7 Million
186,342 Added 151.33%
309,482 $82 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $35.3 Million - $58.7 Million
-181,113 Reduced 59.53%
123,140 $35.6 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $14.4 Million - $19.2 Million
86,796 Added 39.91%
304,253 $60.7 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $25 Million - $31.4 Million
138,605 Added 175.78%
217,457 $42.3 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $1.52 Million - $2.12 Million
-10,242 Reduced 11.5%
78,852 $15.1 Million
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $27 Million - $34.9 Million
-220,619 Reduced 71.23%
89,094 $13.1 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $29.2 Million - $43.5 Million
309,713 New
309,713 $38.3 Million
Q1 2020

May 14, 2020

SELL
$84.96 - $109.14 $1.51 Million - $1.94 Million
-17,791 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $582,892 - $734,773
-7,894 Reduced 30.73%
17,791 $1.65 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $813,793 - $1.01 Million
10,617 Added 70.46%
25,685 $1.97 Million
Q2 2019

Aug 15, 2019

SELL
$54.2 - $85.95 $491,431 - $779,308
-9,067 Reduced 37.57%
15,068 $1.3 Million
Q2 2019

Aug 14, 2019

SELL
$54.2 - $85.95 $1.4 Million - $2.22 Million
-25,871 Reduced 51.74%
24,135 $3.42 Million
Q1 2019

May 14, 2019

SELL
$49.45 - $62.8 $7.86 Million - $9.98 Million
-158,970 Reduced 76.07%
50,006 $2.95 Million
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $10.1 Million - $14.4 Million
208,976 New
208,976 $11 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $1.62 Million - $2.04 Million
-34,609 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$35.26 - $47.04 $1.22 Million - $1.63 Million
34,609 New
34,609 $1.63 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.